Cite
Global Mortality of Chronic Inflammatory Demyelinating Polyneuropathy Patients Treated with Intravenous Immunoglobulin versus Steroid Therapies (P10-5.006)
MLA
Kazim Jaffry, et al. “Global Mortality of Chronic Inflammatory Demyelinating Polyneuropathy Patients Treated with Intravenous Immunoglobulin versus Steroid Therapies (P10-5.006).” Wednesday, April 26, Apr. 2023. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........3e33fbc23d3e5d3b23dfe8c59d86e2e6&authtype=sso&custid=ns315887.
APA
Kazim Jaffry, Mustafa Jaffry, Ronak Trivedi, Muhammed Ors, Fahad Mostafa, Anam Shaikh, Kranthi Mandava, Iqra Faiz, Hafiz Khan, & Nizar Souayah. (2023). Global Mortality of Chronic Inflammatory Demyelinating Polyneuropathy Patients Treated with Intravenous Immunoglobulin versus Steroid Therapies (P10-5.006). Wednesday, April 26.
Chicago
Kazim Jaffry, Mustafa Jaffry, Ronak Trivedi, Muhammed Ors, Fahad Mostafa, Anam Shaikh, Kranthi Mandava, Iqra Faiz, Hafiz Khan, and Nizar Souayah. 2023. “Global Mortality of Chronic Inflammatory Demyelinating Polyneuropathy Patients Treated with Intravenous Immunoglobulin versus Steroid Therapies (P10-5.006).” Wednesday, April 26, April. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........3e33fbc23d3e5d3b23dfe8c59d86e2e6&authtype=sso&custid=ns315887.